(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INTELLISEQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

INTELLISEQ

ST13

US500000087597319

Class

42

Filing

87597319

Registration

5633978

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

10/19/2025

Trademark type

Combined

Nice classes

42

Filing date

09/06/2017

Registration date

12/18/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/18/2025

Last transaction

10/19/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/15/2017

First use in commerce

12/16/2017

Drawing code

3

Owner type

16

Owner location

Krakow, Malopolska, PL

Examiner

FIRST,VIVIAN M

Current location

Historical data usage

Mark description

The mark consists of thick circle, broken on the bottom right position, surrounding DNA helix (consisting of two symmetric pentagons with rectangle in the center of each one), localized vertically in the center of the circle (the circle touches both ends of the DNA helix), with a word "intelliseq" on the right site of the figure.

Holders and representatives

Holders

INTELLISEQ

Representatives

Ranjini Acharya Pillsbury Winthrop Shaw Pittman LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Providing websites featuring technology enabling users to analyze and understand their own genetic information; design and development of software in the field of mobile applications featuring technology enabling users to analyze and understand their own genetic information; providing websites featuring technology enabling users to analyze the results of their genetic testing and analysis for use in connection with dietnutritionweight lossmetabolismbaldnesssport and health care; design and development of software in the field of mobile applications featuring technology enabling users to analyze the results of their genetic testing and analysis for use in connection with dietnutritionweight lossmetabolismbaldnesssport and health care; providing the results of genetic testing and analysis for assessment of fitness and optimization of fitness; application service providerhostingmanagingdevelopingmaintaining mobile applicationscomputer softwareweb sitesin the fields of genetic and bioinformatics testing for medical research and scientific research purposes; providing medical research and scientific research information in the field of molecular genetics; DNA analysis and screening for scientific research purposes; compiling data for research purposes in the field of medical science and medical consultancy for use in connection with diagnostic testing; genetic mapping for scientific purposes; providing information in the field of disease classification for use in connection with diagnostic testing; medical and scientific research in the field of genetic testingdiagnosistreatmenthealth maintenance; providing a website featuring software for patient access to genetic informationdiagnosistreatmenthealth maintenance; design and development of software in the field of mobile applications featuring software for patient access to genetic informationdiagnosistreatmenthealth maintenance bioinformatics interpretation of health data; analysis and screening of nucleic acids for scientific research purposes; genome mapping for scientific purposes; development of scientific research and technology for purposes of disease diagnosispreventative health carehealth monitoringpersonalized treatment; scientific and medical researchidentifying drug targetsdrug dosing and safety for diagnostic or treatment purposes; scientific research relating to population health management

Publications

History of USPTO decisions and trademark events.

28 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

10/18/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

10/18/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/18/2025

E815

TEAS SECTION 8 & 15 RECEIVED

06/18/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/18/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/18/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/13/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/12/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/29/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/29/2018

IUAF

USE AMENDMENT FILED

09/07/2018

EISU

TEAS STATEMENT OF USE RECEIVED

09/07/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/10/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/13/2018

PUBO

PUBLISHED FOR OPPOSITION

02/13/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/24/2018

ALIE

ASSIGNED TO LIE

01/01/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/18/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/18/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/18/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/18/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/07/2017

GNRT

NON-FINAL ACTION E-MAILED

12/07/2017

CNRT

NON-FINAL ACTION WRITTEN

12/07/2017

DOCK

ASSIGNED TO EXAMINER

12/07/2017

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/13/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/12/2017

NWAP

NEW APPLICATION ENTERED

09/09/2017

Continuous trademark protection

Get notified about every new filing that threatens INTELLISEQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.